The recent development of protein kinase CK2 inhibitors as anti-cancer agents [15, 32, 33] and the evidence of CK2-expression in lymphocytes of reactive germinal centers (this paper and [18]) prompted us to investigate CK2 in a large series of FLs, DLBCLs and BLs. Here, WEE1 is linked to cancer.